Brief: Firebrick Pharma Says Withdrew Its Appeal With Administrative Appeals Tribunal (AAT)
26/12/2023 22:34
Dec 27 (Reuters) - Firebrick Pharma Ltd FRE.AX :
* WITHDREW ITS APPEAL WITH ADMINISTRATIVE APPEALS TRIBUNAL
(AAT)
AGAINST TGA'S DECISION NOT TO APPROVE NASODINE NASAL SPRAY
Source text for Eikon: ID:nASX59WtVb
Further company coverage: FRE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement